Skip to main content
Top
Published in: Journal of Clinical Immunology 4/2013

01-05-2013 | Brief Communication

C5 Complement Deficiency in a Saudi Family, Molecular Characterization of Mutation and Literature Review

Authors: Rand Arnaout, Sahar Al Shorbaghi, Hasan Al Dhekri, Hamoud Al-Mousa, Abdulaziz Al Ghonaium, Bandar Al Saud, Saleh Al Muhsen, Lina Al Baik, Abbas Hawwari

Published in: Journal of Clinical Immunology | Issue 4/2013

Login to get access

Abstract

Introduction

Complement deficiencies are rare primary immunodeficiency disorders, the diagnosis of which is often underestimated. Only a small number of molecular studies have been carried out for the characterization of the underlying genetic defects in these cases.

Purpose

Reporting the first family from the Arabian Gulf region with multiple members affected by meningococcemia and abscent serum complement 5 (C5). We tried to correlate clinical, biochemical and molecular genetics features of this family.

Methods

Determination of the serum level of all complement proteins including the terminal cascade (C5-9), followed by mutation analysis on DNA extracted from fresh blood samples of each alive family member.

Results

Molecular studies showed a homozygous nonsense mutation in exon 1, with the change of cytosine to thymine at position 55 (55C > T) leading to change of the glutamine amino acid at position 19 to a stop codon (Q19X), and serologically absence of C5 in the serum. A similar but compound heterozygous mutation has been reported in one African–American family. previously.

Conclusion

Characterization of the underlying mutations in C5 deficient families is important, to understand this uncommon complement deficiency, and try to elucidate structure–function relationships in the C5 gene. This report also highlights the importance of complement screening in cases of sporadic meningococcal Infections, especially in communities with high prevalence of consanguineous marriages, which will ensure timely and adequate clinical interventions.
Appendix
Available only for authorised users
Literature
1.
go back to reference Figueroa JE, Densen P. Infectious diseases associated with complement deficiencies. Clin Microbiol Rev. 1991;4:359–95.PubMed Figueroa JE, Densen P. Infectious diseases associated with complement deficiencies. Clin Microbiol Rev. 1991;4:359–95.PubMed
2.
go back to reference Miller ME, Nilsson UR. A familial deficiency of the phagocytosis-enhancing activity serum related to a dysfunction of the fifth component of complement(C5) N. Engl J Med. 1970;282(7):354–35.CrossRef Miller ME, Nilsson UR. A familial deficiency of the phagocytosis-enhancing activity serum related to a dysfunction of the fifth component of complement(C5) N. Engl J Med. 1970;282(7):354–35.CrossRef
3.
go back to reference Ross SC, Densen P. Complement deficiency states and infection: epidemiology, pathogenesis and consequences of Neisserial and other infections in an immune deficiency. Med (Baltimore). 1984;63:243–73.CrossRef Ross SC, Densen P. Complement deficiency states and infection: epidemiology, pathogenesis and consequences of Neisserial and other infections in an immune deficiency. Med (Baltimore). 1984;63:243–73.CrossRef
4.
go back to reference Carney DF, Haviland DL, Noack D, Wetsel RA, Vik DP, Tack BF. Structural aspects of the human C5 gene. Intron/exon organization, 5_ flanking region features, and characterization of two truncated cDNA clones. J Biol Chem. 1991;266:18786–91.PubMed Carney DF, Haviland DL, Noack D, Wetsel RA, Vik DP, Tack BF. Structural aspects of the human C5 gene. Intron/exon organization, 5_ flanking region features, and characterization of two truncated cDNA clones. J Biol Chem. 1991;266:18786–91.PubMed
5.
go back to reference Ware CF, Kolb WP. Assembly of the functional membrane attack complex of human complement: formation of disulfide-linked C9 dimers. Proc Natl Acad Sci U S A. 1981;78(10):6426–30.PubMedCrossRef Ware CF, Kolb WP. Assembly of the functional membrane attack complex of human complement: formation of disulfide-linked C9 dimers. Proc Natl Acad Sci U S A. 1981;78(10):6426–30.PubMedCrossRef
6.
go back to reference Haeney M, Ball A, Thompson R. Recurrent bacterial meningitis due to genetic deficiencies of terminal complement components (C5 and C6). Immunobiology. 1980;158(1–2):101–6.PubMedCrossRef Haeney M, Ball A, Thompson R. Recurrent bacterial meningitis due to genetic deficiencies of terminal complement components (C5 and C6). Immunobiology. 1980;158(1–2):101–6.PubMedCrossRef
7.
go back to reference Haviland DL, Haviland JC, Fleischer DT, Hunt A, Westel RA. Complete cDNA sequence of human complement pro-C5. Evidence of truncated transcripts derived from a single copy gen. J Immunol. 1991;146:362–8.PubMed Haviland DL, Haviland JC, Fleischer DT, Hunt A, Westel RA. Complete cDNA sequence of human complement pro-C5. Evidence of truncated transcripts derived from a single copy gen. J Immunol. 1991;146:362–8.PubMed
8.
go back to reference Peter G, Weigert MB, Bissel AR, Gold R, Kreutzer D, Mclean RH. Meningoccocal meningitis in familial deficiency of the fifth component of complement. Pediatrics. 1981;67:882–6.PubMed Peter G, Weigert MB, Bissel AR, Gold R, Kreutzer D, Mclean RH. Meningoccocal meningitis in familial deficiency of the fifth component of complement. Pediatrics. 1981;67:882–6.PubMed
9.
go back to reference Delgado-Cerviño E, Fontan G, Lopez-Trascasa M. C5 complement deficiency in a Spanish family. Molecular characterization of the double mutation responsible for the defect. Mol Immunol. 2005;42(1):105–11.PubMedCrossRef Delgado-Cerviño E, Fontan G, Lopez-Trascasa M. C5 complement deficiency in a Spanish family. Molecular characterization of the double mutation responsible for the defect. Mol Immunol. 2005;42(1):105–11.PubMedCrossRef
10.
go back to reference Aguilar-Ramirez P, Reis ES, Florido MP, Barbosa AS, Farah CS, Costa-Carvalho BT. Isaac L Skipping of exon 30 in C5 gene results in complete human C5 deficiency and demonstrates the importance of C5d and CUB domains for stability. Mol Immunol. 2009;46(10):2116–23.PubMedCrossRef Aguilar-Ramirez P, Reis ES, Florido MP, Barbosa AS, Farah CS, Costa-Carvalho BT. Isaac L Skipping of exon 30 in C5 gene results in complete human C5 deficiency and demonstrates the importance of C5d and CUB domains for stability. Mol Immunol. 2009;46(10):2116–23.PubMedCrossRef
11.
go back to reference Zerzri Y, Kallel-Sellami M, Abdelmalek R, Laadhar L, Ben Chaabane T, Makni S. Hereditary complement C5 deficiency: study of 3 Tunisian adult cases and literature review. Tunis Med. 2010;88(4):269–76.PubMed Zerzri Y, Kallel-Sellami M, Abdelmalek R, Laadhar L, Ben Chaabane T, Makni S. Hereditary complement C5 deficiency: study of 3 Tunisian adult cases and literature review. Tunis Med. 2010;88(4):269–76.PubMed
12.
go back to reference Wang X, Fleischer DJ, Whitehead WT, Haviland DL, Rosenfeld SI, Leddy JP, et al. Inherited human complement C5 deficiency in three African–American families. J Immunol. 1995;154(10):5464–71.PubMed Wang X, Fleischer DJ, Whitehead WT, Haviland DL, Rosenfeld SI, Leddy JP, et al. Inherited human complement C5 deficiency in three African–American families. J Immunol. 1995;154(10):5464–71.PubMed
13.
go back to reference Snyderman R, Durack DT, McCarty GA, Ward FE, Meadows L. Deficiencyof the fifth complement in human subjects. Clinical, genetic and immunologic studies in a large kindred. Am J Med. 1979;67(4):638–45.PubMedCrossRef Snyderman R, Durack DT, McCarty GA, Ward FE, Meadows L. Deficiencyof the fifth complement in human subjects. Clinical, genetic and immunologic studies in a large kindred. Am J Med. 1979;67(4):638–45.PubMedCrossRef
14.
go back to reference López-Lera A, Garrido S, de la Cruz RM, Fontán G, López-Trascasa M. Molecular characterization of three new mutations causing C5 deficiency in two non-related families. Mol Immunol. 2009;46(11–12):2340–7.PubMedCrossRef López-Lera A, Garrido S, de la Cruz RM, Fontán G, López-Trascasa M. Molecular characterization of three new mutations causing C5 deficiency in two non-related families. Mol Immunol. 2009;46(11–12):2340–7.PubMedCrossRef
15.
go back to reference Greisenegger S, Zehetmayer S, Bauer P, Endler G, Ferrari J, Lang W, et al. Polymorphisms in inflammatory genes and the risk of ischemic stroke and transient ischemic attack: results of a multilocus genotyping assay. Clin Chem. 2009;55(1):134–8.PubMedCrossRef Greisenegger S, Zehetmayer S, Bauer P, Endler G, Ferrari J, Lang W, et al. Polymorphisms in inflammatory genes and the risk of ischemic stroke and transient ischemic attack: results of a multilocus genotyping assay. Clin Chem. 2009;55(1):134–8.PubMedCrossRef
16.
go back to reference Sanal O, Loos M, Ersoy F, Kanra G, Secmeer G, Tezcan I. Complement component deficiencies and infection: C5 C8 and C3 deficiencies in three families. Eur J Pediatr. 1992;151(9):676–9.PubMedCrossRef Sanal O, Loos M, Ersoy F, Kanra G, Secmeer G, Tezcan I. Complement component deficiencies and infection: C5 C8 and C3 deficiencies in three families. Eur J Pediatr. 1992;151(9):676–9.PubMedCrossRef
17.
go back to reference Pfarr N, Prawitt D, Kirschfink M, Schroff C, Knuf M, Habermehl P, et al. Linking C5 deficiency to an exonic, splicing enhancer mutation. J Immunol. 2005;174(7):4172–7.PubMed Pfarr N, Prawitt D, Kirschfink M, Schroff C, Knuf M, Habermehl P, et al. Linking C5 deficiency to an exonic, splicing enhancer mutation. J Immunol. 2005;174(7):4172–7.PubMed
18.
go back to reference Grimnes G, Beckman H, Lappegård KT, Mollnes TE, Skogen V. Recurrent meningococcal sepsis in presumptive immunocompetent host shown to be complement C5 deficient—a case report. APMIS. 2011;119:479–84.PubMedCrossRef Grimnes G, Beckman H, Lappegård KT, Mollnes TE, Skogen V. Recurrent meningococcal sepsis in presumptive immunocompetent host shown to be complement C5 deficient—a case report. APMIS. 2011;119:479–84.PubMedCrossRef
Metadata
Title
C5 Complement Deficiency in a Saudi Family, Molecular Characterization of Mutation and Literature Review
Authors
Rand Arnaout
Sahar Al Shorbaghi
Hasan Al Dhekri
Hamoud Al-Mousa
Abdulaziz Al Ghonaium
Bandar Al Saud
Saleh Al Muhsen
Lina Al Baik
Abbas Hawwari
Publication date
01-05-2013
Publisher
Springer US
Published in
Journal of Clinical Immunology / Issue 4/2013
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-013-9872-7

Other articles of this Issue 4/2013

Journal of Clinical Immunology 4/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.